1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. SOLIGENIX INC
Soligenix Inc
XNAS: SNGX
0.35-0.01(-2.78%)
216.9K
XNAS Volume

XNAS 16 Oct, 2026 5:30 PM (EDT)

Portfolio

Alert

My Notes

Soligenix Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Soligenix Inc quarterly results: revenue, profit, and P&L – 13 quarter history

  • NEUTRAL

    Quarterly Revenue Soligenix Inc Jun-2026 Quarterly Revenue is $0 Million which is growth of 0% YoY.

  • POSITIVE

    Quarterly Net Profit Soligenix Inc Jun-2026 Quarterly Net Profit is $-2 Million which is growth of 26.4% YoY.

Soligenix Inc, Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphJun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23
Operating Rev.
0.1
Cost Of Rev.
0.10.20.10.2
Gross Profit
-0.2-0.1-0.2
⌄
2.12.93.52.62.83.33.71.91.821.91.71.4
Operating Profit
-2.1-2.9-3.5-2.6-2.8-3.3-3.7-1.9-1.8-2-2.1-1.8-1.6
0.10.10.10.10.10.10.10.1000.10.1-0.1
Profit Before Tax
-2-2.8-3.4-2.5-2.7-3.2-3.4-1.7-1.6-1.9-2.4-1.7-1.6
Tax
-------0.4-0.6
⌄
-2-2.8-2.9-2.5-2.7-3.2-3-1.7-1.6-1.9-1.8-1.7-1.6
Diluted NI Avail to Com Stockholders Ann.
-2-2.8-2.9-2.5-2.7-3.2-3-1.7-1.6-1.9-1.8-1.7-1.6
Basic EPS
-0.1-0.30.2-0.6-0.8-1.1-1.1-0.8-1.3-2.9-2.6-2.6-3.5
Diluted EPS After ExtraOrdinary
-0.1-0.3-0.3-0.6-0.8-1.1-1.3-0.8-1.4-3.1-2.2-2.6-3.7
Number Of Shares End
1610.210.14.33.33.12.52.21.30.70.70.70.5
Net Income Continuing Discontinued Operations
-2-2.8-2.9-2.5-2.7-3.2-3-1.7-1.6-1.9-1.8-1.7-1.6
Normalized Income
-1.9-2.7-2.6-2.4-2.6-3.2-3.1-1.7-1.7-2.2-1.2-1.7-1.6
Interest Income
0.1---0.1--------
Interest
------------0.1
Net Interest Income
0.10.10.10.10.10.10.10.1000.10.1-0.1
EBIT
-2-2.9-3.5-2.6-2.8-3.3-3.5-1.8-1.7-1.9-2.5-1.7-1.6
EBITDA
-2-2.9-3.5-2.6-2.8-3.3-3.5-1.8-1.7-1.9-2.5-1.7-1.6
Reconciled Cost Of Rev.
0.10.20.10.2
Reconciled Depr.
Profit From Continuing Operations
-2-2.8-2.9-2.5-2.4-3.2-3-1.7-1.6-1.9-1.8-1.7-1.6
Normalized EBITDA
-2.1-2.9-3.5-2.6-2.8-3.3-4-1.9-1.9-2.2-2-1.8-1.6
*All financials are in USD Million and price data in USD

Soligenix Inc competitor comparison and performance snapshot within industry

Soligenix Inc annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

  • NEUTRAL

    Annual Revenue Soligenix Inc Annual Revenue is $0 Million which is growth of 0% YoY.

  • NEGATIVE

    Annual Net Profit Soligenix Inc Annual Net Profit is $-11 Million which is growth of -34.0% YoY.

Soligenix Inc, Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsTTMDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
-
-
 0.301.93.244.810.58.8
Cost Of Rev. Ann.
-47.7%
-51.2%
 0.10.70.60.71.83.64.64.38.46.9
Gross Profit Ann.
-
-
 -0.1-0.7-0.3-0.70.1-0.4-0.60.421.9
Operating Exp. Ann.
-4.8%
-8.5%
1111.99.46.913.812.318.69.88.487.79
Operating Profit Ann.
-
-
-11-11.9-9.5-7.7-14.1-13-18.5-10.1-9.1-7.6-5.7-7.1
-
-
0.20.30.2-0.1-0.8-0.9-00.20.20-0
Other Exp. Ann.
-
-
 -00.6-0.2-00.4-0-0--1.9-1.2
PBT Ann.
-
-
-10.7-11.6-8.7-7.9-15-13.4-18.5-10-8.9-7.6-3.8-8.3
Tax Ann.
-
-
 -0.5-0.4-1.8-1.2-0.9-0.8-0.6-0.4-0.5-0.5
⌄
-
-
-10.2-11.1-8.3-6.1-13.8-12.6-17.7-9.4-8.9-7.2-3.3-7.8
Diluted NI Avail to Com Stockholders Ann.
-
-
-10.2-11.1-8.3-6.1-13.8-12.6-17.7-9.4-8.9-7.2-4.8-7.8
EPS Ann.
-
-
 -2.1-5-12.6-69.3-74.4-153.6-115.2-163.2-278.4-223.2-720
Diluted EPS Ann.
-
-
 -2.1-5-12.6-69.3-74.4-153.6-115.2-163.2-278.4-321.6-720
Number Of Shares End
222.9%
151.7%
 10.12.50.70.30.20.10.10.1000
Total Exp. Ann.
-6.2%
-10.2%
 11.99.57.714.41320.413.31312.316.215.9
Net Income Continuing Discontinued Operations Ann.
-
-
-10.2-11.1-8.3-6.1-13.8-12.6-17.7-9.4-8.9-7.2-3.3-7.8
Normalized Income Ann.
-
-
-9.6-10.5-8.5-5.7-13.5-12.6-17.3-9-8.5-6.7-4.8-5.9
Interest Income Ann.
-
-
 ------0.20.2---
Interest Ann.
-
-
 --0.20.10.80.90-----
EBITDA Ann.
-
-
-11-11.9-8.9-7.9-14.1-12.5-18.5-10.1-9-7.5-3.7-8.1
Reconciled Cost Of Rev. Ann.
-47.7%
-51.2%
 0.10.70.60.71.83.64.64.38.46.9
Reconciled Depr. Ann.
-
-
000000.10.100.10.10.3
Profit From Continuing Operations Ann.
-
-
-10.2-11.1-8.3-6.1-13.8-12.6-17.7-9.4-8.9-7.2-3.3-7.8
Normalized EBITDA Ann.
-
-
-11-11.8-10-7.6-14.1-12.9-18.4-10.1-9-7.5-7.6-5.7
*All financials are in USD Million and price data in USD
Operating Exp. Ann.
1Y CHG
26.6%
2Y CAGR
31.3%
3Y CAGR
-4.8%
5Y CAGR
-8.5%
7Y CAGR
5.1%
10Y CAGR
2.8%
Operating Expenses Annual Cr growth is higher than historical averages.

Soligenix Inc balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

  • POSITIVE

    Total Shareholders Fund Soligenix Inc Dec-2025 Total Shareholders Fund is $5 Million which is growth of 28.5% YoY.

  • POSITIVE

    Total Assets Soligenix Inc Dec-2025 Total Assets is $9 Million which is growth of 3.0% YoY.

Soligenix Inc, Balance Sheet, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
-13.7%
-14.3%
9.299.814.326.919.97.810.59.610.37.4
⌄
-38.5%
-24.8%
3.94.97.316.816.216.26.34.23.22.97.4
⌄
-
7.5%
5.34.12.5-2.510.73.71.56.36.37.4-0
Total Capitalization Ann.
-
-17.3%
5.34.13.5-2.520.613.71.56.36.37.4-0
Tangible Assets Ann.
-
7.5%
5.34.12.5-2.510.73.71.46.26.37.3-0.2
Working Capital Ann.
-
-17.2%
5.243.4-2.720.313.41.26.16.27.2-0.3
Invested Capital Ann.
-10.5%
-17.7%
5.35.55.87.420.6141.56.36.37.40.3
Tangible Book Value Ann.
-
7.5%
5.34.12.5-2.510.73.71.46.26.37.3-0.2
Borrowings Ann.
-66%
-48%
0.41.53.510.21010.50.1---0.3
Net Debt Ann.
-
-
-----------
Share Issued Ann.
269.6%
151.7%
10.12.50.70.20.20.10.10.1000
Number Of Shares End
222.9%
151.7%
10.12.50.70.30.20.10.10.1000
*All financials are in USD Million and price data in USD
Total Assets Ann.
1Y CHG
2.2%
2Y CAGR
-3.1%
3Y CAGR
-13.7%
5Y CAGR
-14.3%
7Y CAGR
-1.9%
10Y CAGR
2.2%
Total Assets Annual growth is higher than historical averages.
Total Current Liabilities Ann.
1Y CHG
-24.5%
2Y CAGR
-22.7%
3Y CAGR
-39.2%
5Y CAGR
-9.5%
7Y CAGR
-1.8%
10Y CAGR
-6.7%
Total Current Liabilities Annual Cr is falling faster than historical averages.
Total ShareHolders Funds Ann.
1Y CHG
29.3%
2Y CAGR
45.6%
5Y CAGR
7.5%
7Y CAGR
-2.4%
Total ShareHolders Funds Annual growth is stable compared to historical averages.

Soligenix Inc ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

  • NEGATIVE

    Book Value Per Share Soligenix Inc Book Value Per Share is $1 which is growth of -68.1% YoY.

  • NEUTRAL

    ROE Soligenix Inc ROE is 0% which is growth of 0% YoY.

Soligenix Inc, Ratios, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
RoA Ann. %
-
-
--88.11%-51.01%-67.06%-53.68%-127.87%-102.43%-88.82%-72.13%-36.77%-109.21%
ROE Ann. %
-
-
--248.97%-23,803.12%-334.43%-173.54%-680.46%-241.83%-141.27%-104.21%-87.96%-
ROIC %
-
-
--43.5-27.1--19.6-49.6-129.9-40.6-45.2-6.9-
OPM Ann. %
-
-
----5,642.42%-38,878.92%-957.83%-314.32%-228.44%-159.89%-54.64%-81.09%
Inventory Turnover Ratio Ann.
-
-
-----------
Asset Turnover Ann. %
-
-
---00.10.40.40.51.21.2
Working Capital Turnover Ann.
-
-
-0.10.12.70.70.81.4-34.5
Quick Ratio Ann.
-
-
-1.61.40.84.23.21.12.42.83.50.9
Current Ratio Ann.
-
-
-1.81.60.84.23.21.22.52.93.51
Interest Coverage Ratio Ann.
-
-
---160-17.2-14.6-1,701.4-----
LT Debt To Equity Ann.
-
-
--0.5-0.92.7----
*All financials are in USD Million and price data in USD

Soligenix Inc cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

  • NEGATIVE

    Cash From Operating Activity Soligenix Inc Cash From Operating Activity is $-10 Million which is growth of -22.2% YoY.

  • NEUTRAL

    Net Cash Flow Soligenix Inc Net Cash Flow is $0 Million which is growth of 0% YoY.

Soligenix Inc, Cash Flow, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
-
-
-10.3-8.4-8.6-12.7-11.7-11.5-7.5-7.2-6.5-5-5.4
-
-
-0--0-0-0-0-0-0-0
370.3%
-15.9%
10.47.83.70.119.124.748.45.68.84.8
Cash Plus Cash Eqv. End Of Year Ann.
-16.1%
-15.8%
7.97.88.513.42618.75.497.88.84.9
Net Increase In Cash Plus Cash Eqv.s Ann.
-
-62.3%
0.1-0.6-4.9-12.67.313.2-3.51.2-13.9-0.6
Cash Plus Cash Eqv. Begin Of Year Ann.
-33.1%
7.6%
7.88.513.42618.75.497.88.84.95.5
Income Tax Paid Supplemental Data Ann.
-
-
0.100000000
Interest Paid Supplemental Data Ann.
-
-
00.20.60.90.70-----
Capex Ann.
-
-
-0---0-0-0-0-0-0-0
Issuance Of Capital Stock Ann.
396%
-3.5%
12.25.811.60.119.714.64.18.76.3103.8
Issuance Of Debt Ann.
-
-
----10-----
Repayment Of Debt Ann.
-
-
-1.4-1.4-7-0-0-0--0.3-
Repurchase Of Capital Stock Ann.
-
-
-----------
Free Cash Flow Ann.
-
-
-10.3-8.4-8.6-12.7-11.8-11.5-7.5-7.3-6.5-5-5.4
*All financials are in USD Million and price data in USD
Cash from Financing Act. Ann.
1Y CHG
33.3%
2Y CAGR
67.7%
3Y CAGR
370.3%
5Y CAGR
-15.9%
7Y CAGR
3.1%
10Y CAGR
8%
Cash from Financing Annual Activity growth is stable compared to historical averages.